Why Is ADC Therapeutics Stock Falling Thursday?

ADC Therapeutics SA (NYSE:ADCT) stock is trading lower on Thursday after the company indicated that LOTIS-5 showed elevated serious and Grade 5 adverse events, and it will discuss the benefit-risk profile with the FDA. LOTIS-5 Meets Primary Endpoint ADC Therapeutics...

Broadcom Says AI Demand Is ‘Insatiable’

Broadcom Inc. (NASDAQ:AVGO) stock fell in premarket trading Thursday after the chipmaker reported fiscal second-quarter 2026 results that topped earnings estimates but failed to satisfy Wall Street’s elevated expectations for artificial intelligence growth. While the...